Elamipretide for Mytochondrial Myopathy

<p><span data-sheets-value= "{"1":2,"2":"Dr. Justin Abbatemarco talks with Dr. Amel Karaa about the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies.\n\nRead the related article in Neurology. \n\nVisit NPUb.org/Podcast for associated article links."}" data-sheets-userformat= "{"2":4815,"3":{"1":0},"4":{"1":2,"2":14277081},"5":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"6":{"1":[{"1":2,"2":0,"5":{"1":2,"2":0}},{"1":0,"2":0,"3":3},{"1":1,"2":0,"4":1}]},"9":1,"10":1,"12":0,"15":"Arial"}"> Dr. Amel Karaa discusses the use of elamipretide in participants with genetically confirmed primary mitochondrial myopathies.<br /></span></p> <p>Show references: <a href= "https://n.neurology.org/content/101/3/e238">https://n.neurology.org/content/101/3/e238</a></p> <p> </p>